About The Author

Egle Solito currently works at the William Harvey Research Institute, SMD, Queen Mary University of London-UK. Egle's team research is centred on the impact of inflammation and metabolism at the intersection between the immune system and the blood-brain barrier. The lab study diseases such as Multiple Sclerosis, Alzheimer and Diabetes. The lab use in vivo approach on animal model as well as ex vivo and in vitro model (murine and human) of BBB.

Is AnnexinA1 The Miracle Drug For Diabetes?

Type-1 diabetes is a genetic disease which develops as a result of auto-immunity against insulin-producing cells in the pancreas. Essentially immune cells, which are designed to attack foreign pathogens (bacteria and viruses) attack cells from their own body. This leads to a destruction of insulin-producing cells, and a subsequent lack of insulin production, eventually leading